xihan wu

Xihan Wu is the Founder of InnoMed Capital, a role they have held since 2018. Prior to this, they co-founded PharmaBlock Sciences (Nanjing), Inc., serving as both Co-Founder and Chief Operating Officer from 2010 to 2018. Xihan also held the position of Director of Med Chem at Roche's China site from 2004 to 2009. Their educational background includes a PhD in Medicinal Chemistry from the Shanghai Institute of Materia Medica and multiple postdoctoral positions in organic synthesis and drug discovery at prestigious institutions, including the University of Virginia and Georgetown University School of Medicine.